Tumor necrosis factor-α (TNF-α)-induced and interleukin-1β (IL-1β)-induced shedding of TNF receptors from gingival fibroblasts

被引:20
作者
Ohe, H
Takashiba, S
Naruishi, K
Chou, HH
Yamada, H
Nishimura, F
Arai, H
Murayama, Y
机构
[1] Okayama Univ, Sch Dent, Dept Periodontol & Endodontol, Okayama 7008525, Japan
[2] Taipei Med Coll, Sch Dent, Taipei, Taiwan
关键词
D O I
10.1089/107999000750053744
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor necrosis factor-alpha (TNF-alpha) exerts its functions by binding two different receptors (TNFR55 and TNFR75), Both TNFR55 and TNFR75 exist in cell-associated and soluble forms. Soluble TNF receptors (sTNFR), sTNFR55 and sTNFR75, are proteolytically shed upon inflammatory stimuli and then modulate various TNF-alpha bioactivities. As human gingival fibroblasts (HGF) can be potential targets for TNF-alpha in inflamed gingiva, we hypothesized that HGF partially modulate the cellular responses to TNF-alpha by regulating their own TNFR. In this study, the kinetics of expression of cell-associated and soluble forms of both receptors from cultured HGF in response to proinflammatory cytokines TNF-alpha and interleukin-1 beta (IL-1 beta) were investigated in vitro. Both TNF-alpha and IL-1 beta upregulated the gene expression of TNFR75 and did not affect that of TNFR55. TNF-alpha and IL-1 beta decreased binding of [I-125]TNF-alpha to HGF. Moreover, TNF-alpha and IL-1 beta upregulated the release of sTNFR75 from HGF but not that of sTNFR55, These results suggest that HGF under inflammatory conditions may contribute to the inactivation of circulating TNF-a through the preferential induction and shedding of TNFR75.
引用
收藏
页码:1077 / 1082
页数:6
相关论文
共 27 条
[1]   SYNTHESIS OF PROINFLAMMATORY CYTOKINES BY HUMAN GINGIVAL FIBROBLASTS IN RESPONSE TO LIPOPOLYSACCHARIDES AND INTERLEUKIN-1-BETA [J].
AGARWAL, S ;
BARAN, C ;
PIESCO, NP ;
QUINTERO, JC ;
LANGKAMP, HH ;
JOHNS, LP ;
CHANDRA, CS .
JOURNAL OF PERIODONTAL RESEARCH, 1995, 30 (06) :382-389
[2]  
Alaaeddine N, 1997, J RHEUMATOL, V24, P1985
[3]  
Alsalameh S, 1999, J RHEUMATOL, V26, P645
[4]  
Assuma R, 1998, J IMMUNOL, V160, P403
[5]   INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SERA AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATIC DISEASES [J].
COPE, AP ;
ADERKA, D ;
DOHERTY, M ;
ENGELMANN, H ;
GIBBONS, D ;
JONES, AC ;
BRENNAN, FM ;
MAINI, RN ;
WALLACH, D ;
FELDMANN, M .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1160-1169
[6]  
Edwards CK, 1999, ANN RHEUM DIS, V58, P73
[7]  
ENGELMANN H, 1990, J BIOL CHEM, V265, P1531
[8]   Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis [J].
Graves, DT ;
Delima, AJ ;
Assuma, R ;
Amar, S ;
Oates, T ;
Cochran, D .
JOURNAL OF PERIODONTOLOGY, 1998, 69 (12) :1419-1425
[9]   MULTIFUNCTIONAL REGULATION OF THE BIOLOGICAL EFFECTS OF TNF-ALPHA BY THE SOLUBLE TYPE-I AND TYPE-II TNF RECEPTORS [J].
HALE, KK ;
SMITH, CG ;
BAKER, SL ;
VANDERSLICE, RW ;
SQUIRES, CH ;
GLEASON, TM ;
TUCKER, DD ;
KOHNO, T ;
RUSSELL, DA .
CYTOKINE, 1995, 7 (01) :26-38
[10]  
Haridas V, 1998, J IMMUNOL, V160, P3152